8. History of active or prior malignancy that will interfere with the response evaluation (exceptions include in‐situ carcinoma of the cervix treated by cone‐biopsy/resection, nonmetastatic basal and/or squamous cell carcinomas of the skin, any early stage (stage l) malignancy adequately resected for cure greater than 5 years previously).